EDIT vs ESS
Editas Medicine Inc (EDIT) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ESS revenue for 2024-12-31 was $1.77B. Net income was $811.3M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
EDIT currently screens at market cap $375.2M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the EDIT and ESS stock pages for the full models.
Not investment advice.